Evaluation of Platelet Activation by HIV Protease Inhibitors – The HIV-PLA II Study

BACKGROUND: In the past, protease inhibitors (PIs) and the reverse transcriptase inhibitor abacavir were identified increasing the risk for thromboembolic complications and cardiovascular events (CVE) of HIV infected patients taking a combination antiretroviral therapy (cART). Results of the previou...

Descripción completa

Detalles Bibliográficos
Autores principales: Kann, Gerrit, Owasil, Junaid, Kuczka, Karina, Haberl, Annette, Wolf, Timo, Khaykin, Pavel, Harder, Sebastian, Stephan, Christoph, von Hentig, Nils
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354741/
https://www.ncbi.nlm.nih.gov/pubmed/34393518
http://dx.doi.org/10.2147/HIV.S262282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354741/
https://www.ncbi.nlm.nih.gov/pubmed/34393518
http://dx.doi.org/10.2147/HIV.S262282

Ejemplares similares